219 related articles for article (PubMed ID: 28821955)
1. Targeted next-generation sequencing for analyzing the genetic alterations in atypical adenomatous hyperplasia and adenocarcinoma in situ.
Xu X; Li N; Zhao R; Zhu L; Shao J; Zhang J
J Cancer Res Clin Oncol; 2017 Dec; 143(12):2447-2453. PubMed ID: 28821955
[TBL] [Abstract][Full Text] [Related]
2. Targeted sequencing reveals clonal genetic changes in the progression of early lung neoplasms and paired circulating DNA.
Izumchenko E; Chang X; Brait M; Fertig E; Kagohara LT; Bedi A; Marchionni L; Agrawal N; Ravi R; Jones S; Hoque MO; Westra WH; Sidransky D
Nat Commun; 2015 Sep; 6():8258. PubMed ID: 26374070
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation changes in atypical adenomatous hyperplasia, adenocarcinoma in situ, and lung adenocarcinoma.
Selamat SA; Galler JS; Joshi AD; Fyfe MN; Campan M; Siegmund KD; Kerr KM; Laird-Offringa IA
PLoS One; 2011; 6(6):e21443. PubMed ID: 21731750
[TBL] [Abstract][Full Text] [Related]
4. Disproportionate representation of KRAS gene mutation in atypical adenomatous hyperplasia, but even distribution of EGFR gene mutation from preinvasive to invasive adenocarcinomas.
Sakamoto H; Shimizu J; Horio Y; Ueda R; Takahashi T; Mitsudomi T; Yatabe Y
J Pathol; 2007 Jul; 212(3):287-94. PubMed ID: 17534846
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation profile during multistage progression of pulmonary adenocarcinomas.
Chung JH; Lee HJ; Kim BH; Cho NY; Kang GH
Virchows Arch; 2011 Aug; 459(2):201-11. PubMed ID: 21494759
[TBL] [Abstract][Full Text] [Related]
6. A subset of lung adenocarcinomas and atypical adenomatous hyperplasia-associated foci are genotypically related: an EGFR, HER2, and K-ras mutational analysis.
Sartori G; Cavazza A; Bertolini F; Longo L; Marchioni A; Costantini M; Barbieri F; Migaldi M; Rossi G
Am J Clin Pathol; 2008 Feb; 129(2):202-10. PubMed ID: 18208799
[TBL] [Abstract][Full Text] [Related]
7. Differentiation of atypical adenomatous hyperplasia and adenocarcinoma of the lung by use of DNA ploidy and morphometric analysis.
Yokozaki M; Kodama T; Yokose T; Matsumoto T; Mukai K
Mod Pathol; 1996 Dec; 9(12):1156-64. PubMed ID: 8972475
[TBL] [Abstract][Full Text] [Related]
8. Multi-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinoma.
Hu X; Fujimoto J; Ying L; Fukuoka J; Ashizawa K; Sun W; Reuben A; Chow CW; McGranahan N; Chen R; Hu J; Godoy MC; Tabata K; Kuroda K; Shi L; Li J; Behrens C; Parra ER; Little LD; Gumbs C; Mao X; Song X; Tippen S; Thornton RL; Kadara H; Scheet P; Roarty E; Ostrin EJ; Wang X; Carter BW; Antonoff MB; Zhang J; Vaporciyan AA; Pass H; Swisher SG; Heymach JV; Lee JJ; Wistuba II; Hong WK; Futreal PA; Su D; Zhang J
Nat Commun; 2019 Jul; 10(1):2978. PubMed ID: 31278276
[TBL] [Abstract][Full Text] [Related]
9. Genetic relationship among atypical adenomatous hyperplasia, bronchioloalveolar carcinoma and adenocarcinoma of the lung.
Morandi L; Asioli S; Cavazza A; Pession A; Damiani S
Lung Cancer; 2007 Apr; 56(1):35-42. PubMed ID: 17241687
[TBL] [Abstract][Full Text] [Related]
10. Molecular alterations in atypical adenomatous hyperplasia occurring in benign and cancer-bearing lungs.
Gradowski JF; Mantha GS; Hunt JL; Dacic S
Diagn Mol Pathol; 2007 Jun; 16(2):87-90. PubMed ID: 17525677
[TBL] [Abstract][Full Text] [Related]
11. Genomic Landscape of Atypical Adenomatous Hyperplasia Reveals Divergent Modes to Lung Adenocarcinoma.
Sivakumar S; Lucas FAS; McDowell TL; Lang W; Xu L; Fujimoto J; Zhang J; Futreal PA; Fukuoka J; Yatabe Y; Dubinett SM; Spira AE; Fowler J; Hawk ET; Wistuba II; Scheet P; Kadara H
Cancer Res; 2017 Nov; 77(22):6119-6130. PubMed ID: 28951454
[TBL] [Abstract][Full Text] [Related]
12. Gene amplification and protein expression of EGFR and HER2 by chromogenic in situ hybridisation and immunohistochemistry in atypical adenomatous hyperplasia and adenocarcinoma of the lung.
Awaya H; Takeshima Y; Furonaka O; Kohno N; Inai K
J Clin Pathol; 2005 Oct; 58(10):1076-80. PubMed ID: 16189154
[TBL] [Abstract][Full Text] [Related]
13. Thin-section computed tomography-histopathologic comparisons of pulmonary focal interstitial fibrosis, atypical adenomatous hyperplasia, adenocarcinoma in situ, and minimally invasive adenocarcinoma with pure ground-glass opacity.
Si MJ; Tao XF; Du GY; Cai LL; Han HX; Liang XZ; Zhao JM
Eur J Radiol; 2016 Oct; 85(10):1708-1715. PubMed ID: 27666606
[TBL] [Abstract][Full Text] [Related]
14. Imaging features of TSCT predict the classification of pulmonary preinvasive lesion, minimally and invasive adenocarcinoma presented as ground glass nodules.
Liu Y; Sun H; Zhou F; Su C; Gao G; Ren S; Zhou C; Zhang Z; Shi J
Lung Cancer; 2017 Jun; 108():192-197. PubMed ID: 28625634
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor receptor mutation and p53 overexpression during the multistage progression of small adenocarcinoma of the lung.
Yoo SB; Chung JH; Lee HJ; Lee CT; Jheon S; Sung SW
J Thorac Oncol; 2010 Jul; 5(7):964-9. PubMed ID: 20512074
[TBL] [Abstract][Full Text] [Related]
16. ARL4C is associated with initiation and progression of lung adenocarcinoma and represents a therapeutic target.
Kimura K; Matsumoto S; Harada T; Morii E; Nagatomo I; Shintani Y; Kikuchi A
Cancer Sci; 2020 Mar; 111(3):951-961. PubMed ID: 31925985
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological Characteristics and Mutations Driving Development of Early Lung Adenocarcinoma: Tumor Initiation and Progression.
Inamura K
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29690599
[TBL] [Abstract][Full Text] [Related]
18. Excellent Prognosis of Patients With Invasive Lung Adenocarcinomas During Surgery Misdiagnosed as Atypical Adenomatous Hyperplasia, Adenocarcinoma In Situ, or Minimally Invasive Adenocarcinoma by Frozen Section.
Zhang Y; Deng C; Fu F; Ma Z; Wen Z; Ma X; Wang S; Li Y; Chen H
Chest; 2021 Mar; 159(3):1265-1272. PubMed ID: 33197404
[TBL] [Abstract][Full Text] [Related]
19. Genetic Alterations in Preinvasive Lung Synchronous Lesions.
Ahn S; Lim J; Park SY; Kim H; Kwon HJ; Han YB; Lee CT; Cho S; Chung JH
Cancer Res Treat; 2020 Oct; 52(4):1120-1134. PubMed ID: 32599981
[TBL] [Abstract][Full Text] [Related]
20. Pathomic Features Reveal Immune and Molecular Evolution From Lung Preneoplasia to Invasive Adenocarcinoma.
Chen P; Rojas FR; Hu X; Serrano A; Zhu B; Chen H; Hong L; Bandyoyadhyay R; Aminu M; Kalhor N; Lee JJ; El Hussein S; Khoury JD; Pass HI; Moreira AL; Velcheti V; Sterman DH; Fukuoka J; Tabata K; Su D; Ying L; Gibbons DL; Heymach JV; Wistuba II; Fujimoto J; Solis Soto LM; Zhang J; Wu J
Mod Pathol; 2023 Dec; 36(12):100326. PubMed ID: 37678674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]